首頁 > 市場調查報告書 > 食物/飲料

食品添加劑機能性食品

市場調查報告書

商品編碼

1547597

全球 CROCIN 市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global CROCIN Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球藏紅花素市場需求將從 2023 年的 53.6 億美元達到近 88.1 億美元的市場規模，2024-2032 年研究期間複合年成長率為 5.66%。

藏紅花素是一種基於乙醯胺酚的鎮痛劑和解熱劑，用作止痛劑，可提供快速有效的暫時緩解。它也用於快速有效地緩解感冒、流感症狀和發燒。藏紅花素有針對性地緩解疼痛，可用於治療頭痛、偏頭痛、月經痛、關節炎、牙痛和肌肉骨骼疼痛。該藥物含有經臨床證明的成分，如乙醯胺酚和咖啡因。它透過阻止引起疼痛和發燒的化學信使的釋放來作用於疼痛的中心。成人及12歲以上兒童均可使用。對於患有心血管疾病/心臟病、高血壓、胃敏感和糖尿病患者來說，它被認為是安全的。藏紅花呈顏色的藏紅花素是一種類胡蘿蔔素化合物，存在於藏紅花和梔子花等花朵中。

市場動態

生活方式的改變、由於壓力增加而導致的不同類型疼痛的盛行率增加，特別是在城市人口中，將是市場成長的主要刺激因素。藏紅花素既可以作為鎮痛劑，也可以作為解熱劑，完全緩解疼痛和發燒，這將進一步推動市場成長。藏紅花素在康復計劃中被證明對人們的心理健康狀況有益，這將使市場受益。該藥物的推廣和廣告方面的大量投資將有利於市場成長。提供廣泛的產品來滿足所有年齡層消費者的需求將是市場的助推器。替代品的可用性以及全球一小部分人口報告的副作用將阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對 CROCIN 全球市場的每個細分市場進行了包容性評估。藏紅花素產業的成長和趨勢為本研究提供了整體方法。

市場區隔

CROCIN 市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按申請

食物
化工
藥物
其他

按純度

純度>98%
純度<98%

按指示

疼痛
發熱（發燒）

按配銷通路

醫院藥房
零售藥房
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲地區對番紅花市場的當前和未來需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。 CROCIN 市場的主要參與者包括 TCI Chemicals Pvt.。 Ltd.、Merck KGaA、GSK Plc.、Cayman Chemical、APExBIO Technology、Wilshire Technologies、Biosynth、Cipla Inc.、Novartis AG、Sanofi、Aurobindo Pharma、Teva Pharmaceutical Industries Ltd.、Mallinckrodt。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 市場吸引力分析：依應用分類
- 按純度分析市場吸引力
- 按指標進行的市場吸引力分析
- 按配銷通路分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球藏紅花素市場分析：依應用分類

概述：按應用
歷史和預測數據
分析：按應用
食物
化工
藥物
其他

第 6 章：全球藏紅花素市場分析：依純度

純度概述
歷史和預測數據
純度分析
純度>98%
純度<98% 按地區分類的歷史和預測銷售額

第 7 章：全球藏紅花素市場分析：依適應症分類

按指示概述
歷史和預測數據
按指標分析
疼痛
發熱（發燒）

第 8 章：全球藏紅花素市場分析：按分銷管道

配銷通路概覽
歷史和預測數據
按配銷通路分析
醫院藥房
零售藥房
其他

第 9 章：全球藏紅花素市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：Crocin 公司的競爭格局

藏紅花市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
TCI Chemicals Pvt. Ltd.

公司概況
公司收入
產品
最新動態

Merck KGaA

公司概況
公司收入
產品
最新動態

GSK Plc.

公司概況
公司收入
產品
最新動態

Cayman Chemical

公司概況
公司收入
產品
最新動態

APExBIO Technology

公司概況
公司收入
產品
最新動態

Wilshire Technologies

公司概況
公司收入
產品
最新動態

Biosynth

公司概況
公司收入
產品
最新動態

Cipla Inc.

公司概況
公司收入
產品
最新動態

Novartis AG

公司概況
公司收入
產品
最新動態

Sanofi

公司概況
公司收入
產品
最新動態

Aurobindo Pharma

公司概況
公司收入
產品
最新動態

Teva Pharmaceutical Industries Ltd.

公司概況
公司收入
產品
最新動態

Mallinckrodt

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11214564

The global demand for CROCIN Market is presumed to reach the market size of nearly USD 8.81 Billion by 2032 from USD 5.36 Billion in 2023 with a CAGR of 5.66% under the study period 2024-2032.

Crocin is a paracetamol-based analgesic and antipyretic used as a pain killer to provide fast and effective temporary relief. It is also used for rapid and effective relief from cold & flu symptoms and fever. Crocin offers targeted pain relief and can be used for headaches, migraines, menstrual pain, arthritis, toothache, and musculoskeletal pain. The medication contains clinically proven ingredients like paracetamol and caffeine. It acts at the center of pain by blocking the release of pain and fever-causing chemical messengers. It can be used by adults & children over 12 years. It is considered safe for people with CVD/heart conditions, high blood pressure, sensitive stomach, and diabetics. Crocin responsible for the color of saffron is a carotenoid chemical compound present in the flowers like crocus and gardenia.

MARKET DYNAMICS

Changing lifestyles, increased prevalence of pains of different types due to rising stress, especially among the urban population, will be the main stimulating factors for market growth. Crocin serving both as an analgesic and antipyretic to provide total relief from pain and fever will further propel market growth. Crocin, proven to have beneficial effects on people's mental health status in rehabilitation programs, will benefit the market. Heavy investments in promoting and advertising the drug will favor market growth. Availability of a wide range of products to address consumers' needs of all age groups will be a market booster. Availability of alternatives and the side effects reported by a small portion of the global population will hinder the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of CROCIN. The growth and trends of CROCIN industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the CROCIN market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Food
Chemical Industry
Drug
Others

By Purity

Purity >98%
Purity <98%

By Indication

Pain
Pyrexia (Fever)

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the CROCIN market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the CROCIN market include TCI Chemicals Pvt. Ltd., Merck KGaA, GSK Plc., Cayman Chemical, APExBIO Technology, Wilshire Technologies, Biosynth, Cipla Inc., Novartis AG, Sanofi, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd., Mallinckrodt. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CROCIN - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Purity
- 3.7.3 Market Attractiveness Analysis By Indication
- 3.7.4 Market Attractiveness Analysis By Distribution Channel
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CROCIN MARKET ANALYSIS BY APPLICATION

5.1. Overview By Application
5.2. Historical and Forecast Data
5.3. Analysis By Application
5.4. Food Historic and Forecast Sales By Regions
5.5. Chemical Industry Historic and Forecast Sales By Regions
5.6. Drug Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL CROCIN MARKET ANALYSIS BY PURITY

6.1. Overview By Purity
6.2. Historical and Forecast Data
6.3. Analysis By Purity
6.4. Purity >98% Historic and Forecast Sales By Regions
6.5. Purity <98% Historic and Forecast Sales By Regions

7. GLOBAL CROCIN MARKET ANALYSIS BY INDICATION

7.1. Overview By Indication
7.2. Historical and Forecast Data
7.3. Analysis By Indication
7.4. Pain Historic and Forecast Sales By Regions
7.5. Pyrexia (Fever) Historic and Forecast Sales By Regions

8. GLOBAL CROCIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL

8.1. Overview By Distribution Channel
8.2. Historical and Forecast Data
8.3. Analysis By Distribution Channel
8.4. Hospital Pharmacy Historic and Forecast Sales By Regions
8.5. Retail Pharmacy Historic and Forecast Sales By Regions
8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL CROCIN MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE CROCIN COMPANIES

10.1. CROCIN Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF CROCIN INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. TCI Chemicals Pvt. Ltd.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Merck KGaA
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. GSK Plc.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Cayman Chemical
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. APExBIO Technology
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Wilshire Technologies
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Biosynth
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Cipla Inc.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Novartis AG
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Sanofi
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Aurobindo Pharma
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Teva Pharmaceutical Industries Ltd.
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments
11.15. Mallinckrodt
- 11.15.1 Company Overview
- 11.15.2 Company Revenue
- 11.15.3 Products
- 11.15.4 Recent Developments